Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2018-12-28 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
关于股东股权解除质押暨再质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the release and re-pledging of shares by a major shareholder (China Baoan Group) of the company. It details the number of shares released from pledge and re-pledged, the percentage of total shares involved, and the shareholder's overall shareholding and pledge status. This type of announcement relates to changes in share ownership or share pledging activities by significant shareholders, but it is not a notification of crossing ownership thresholds (which would be MRQ), nor is it a report or financial statement. It is specifically about share pledging and re-pledging, which is a capital structure or financing activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document is short and focused on this financing activity, not a full report or regulatory filing.
2018-12-28 Chinese
2018年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2018 年第三季度报告" which translates to "2018 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the period ending September 30, 2018. The report is unaudited and includes comprehensive financial figures and analysis for the quarter, consistent with an interim or quarterly financial report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual report, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2018
2018-10-28 Chinese
关于媒体报道的澄清公告
Regulatory Filings Classification · 90% confidence The document is a detailed announcement from the board of directors of 马应龙药业集团股份有限公司 addressing media reports about the company's financial and operational status. It includes extensive financial data for the first half of 2018, business segment performance, investment activities, and risk disclosures. The document is not a full annual or interim report but rather a clarifying announcement with financial figures and explanations. It does not fit the profile of a typical earnings release (which is usually shorter and more focused on headline results), nor is it a regulatory filing or certification. It is a comprehensive disclosure aimed at clarifying financial and operational matters to investors and the public, which aligns best with a Regulatory Filings (RNS) classification as it is a general regulatory announcement that does not fit other specific categories like Annual Report or Interim Report. The document length (5481 characters) and content support this classification rather than a report publication announcement or a full financial report.
2018-10-24 Chinese
关于股东股权解除质押暨再质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the release and re-pledging of shares by a major shareholder (China Baoan Group) of the company. It details the number of shares involved, the purpose of the pledge (loan), and the shareholder's current shareholding and pledge status. This type of announcement relates to changes in share ownership or share pledging activities by significant shareholders, which fits the category of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management information, but a regulatory announcement about share pledging activities by a major shareholder.
2018-09-19 Chinese
独立董事关于关联交易的独立意见
Board/Management Information Classification · 95% confidence The document is a statement of independent directors providing their opinion on a related party transaction proposal discussed at a board meeting. It references company regulations and legal compliance but does not contain financial statements or detailed financial data. The document is short (517 characters) and serves as an opinion or certification rather than a full report. It is not an annual report, audit report, or financial report. It is also not a regulatory filing in the sense of officer certification but rather an independent opinion on a board matter. This fits best under Board/Management Information (MANG), which includes announcements related to board decisions and opinions.
2018-09-17 Chinese
关于与关联人共同对外投资的关联交易公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction involving the company and its affiliates investing in a new joint venture company. It details the investment amount, shareholding structure, related parties, and the approval process by the board and independent directors. There are no financial statements or comprehensive financial data presented, nor is this a report of financial results or a regulatory certification. The document is a formal disclosure of a related party transaction, which is a regulatory announcement about corporate actions but not a full financial report or management discussion. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a notice of voting results or a proxy statement. Given the nature of the content and the absence of financial statements, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-09-17 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.